United States · FDA National Drug Code directory

Spironolactone and Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-2202_427160ef-378f-4945-a022-cbf66cb112cc
Product NDC
71335-2202
Form
TABLET
Composition / generic term
Spironolactone and Hydrochlorothiazide
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
19870702
Source listing expiry
20271231

Source-listed ingredients

  • SPIRONOLACTONE — 25 mg/1
  • HYDROCHLOROTHIAZIDE — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET in 1 BOTTLE, PLASTIC (71335-2202-1) · 71335-2202-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →